Study summary

A blood test for tumor HPV DNA detected recurrences with high accuracy

HPV ctDNA surveillance meta-analysis · 12 studies, 1,311 people · Published August 2024, Journal of Experimental & Clinical Cancer Research

96%specificity for detecting recurrence

What was tested

A pooled analysis of studies using circulating tumor HPV DNA blood tests (including TTMV-HPV DNA) to monitor for recurrence after treatment.

What they found

Pooled sensitivity was 86% and specificity 96%.
Authors called for standardized protocols before routine use.

What it means

Blood tests may replace some scans in follow-up and guide future de-escalation trials.

J Exp Clin Cancer Res, via PubMed ↗ ← Back to the outlook

Last reviewed 2026-11-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.